Quince Therapeutics Inc. is scrapping work with dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP) for patients with ataxia-telangiectasia (A-T), and Boral analyst Jason ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min His company has less than $26.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results